Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone marrow cells in LVAD bridge to transplant patients
NCT00383630Phase 2Terminated
- Sponsor
- Columbia University
- Start
- Sep 2007
- Primary completion
- Dec 2008
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bone marrow mononuclear cells and cd34+ selected bone marrow mononuclear cells in heart failure (HF), sponsored by Columbia University. Started Sep 2007; status: terminated.
02
Drugs
bone marrow mononuclear cellscd34+ selected bone marrow mononuclear cells
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00383630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383630.